The chief medical officer is interested in an easier path to market for health screening features in wearable devices.

With Isaac, US company PreEvnt has developed a non-invasive blood sugar monitoring device. The device was presented at CES ...

Comprehensive Analysis of Tirzepatide Access Options as Resolution Season Peaks: MyStart Health Programs, FDA Context, Coverage Developments, and Questions to Consider Before Starting GLP-1 ...

Makers of smartwatches and other wearables have spent years trying to measure blood sugar without pricking your skin. The ...

Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...

With global population growth and climate change posing escalating threats to crop production, the current food system is ...

A comprehensive mini-review published today after peer review in Brain Medicine by Dr. Tao Ma and colleagues at Wake Forest ...

A research team presents an overview of recent advances in the microbial biosynthesis of L-tryptophan (L-Trp) and its structurally diverse derivatives, highlighting how synthetic biology and metabolic ...

Materna Medical's Ellora Obstetrical System is designed to address a critical unmet need in labor and delivery--reducing pelvic floor injuries during vaginal birth. These injuries, often involving ...

PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.